Patent details

EP3013366 Title: COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR

Basic Information

Publication number:
EP3013366
PCT Application Number:
EP2014063691
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147390785
PCT Publication Number:
WO2014207199
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR
French Title of Invention:
THÉRAPIE COMBINÉE UTILISANT UN INHIBITEUR DU FACTEUR XII ET L'INHIBITEUR C1
German Title of Invention:
KOMBINATIONSTHERAPIE MIT EINEM FAKTOR XII-HEMMER UND EINEM C1-HEMMER
SPC Number:

Dates

Filing date:
27/06/2014
Grant date:
25/08/2021
EP Publication Date:
04/05/2016
PCT Publication Date:
31/12/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/06/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
CSL Behring GmbH
Address:
Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/09/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
NOLTE, Marc
Address:
Germany (DE)

2

Name:
PRAGST, Ingo
Address:
Germany (DE)

Priority

1

Priority Number:
201361840662 P
Priority Date:
28/06/2013
Priority Country:
United States (US)

2

Priority Number:
13176605
Priority Date:
16/07/2013
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/57; A61K 39/395; A61K 31/4365; A61K 31/519; A61K 31/60; A61K 31/616; A61K 31/727; A61K 45/06; C07K 16/36; A61P 3/00; A61P 7/02; A61P 7/10; A61P 9/00; A61P 9/10; A61P 11/00; A61P 21/00; A61P 25/00; A61P 29/00; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/06/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
30/09/2021 Power Of Attorney 1
01/10/2021 Outgoing Correspondence 1